NIPRD Flags Nigeria's Reliance on One WHO Antimalarial
NIPRD warns Nigeria's reliance on a single WHO-prequalified antimalarial limits local manufacturing. The institute trains pharma firms to tap into the $161m global market, urging tax reliefs and incentives.